Programming - International Stroke Conference

ISC 2026 Schedule-at-a-Glance

Wednesday, Feb. 4, 2026 Activities
Time Activity
7:30 a.m. to 9:00 a.m.
  • Grey Areas: Decision Making in Difficult Cases
  • Optimizing Stroke Care in Underserved Setting: Challenges and Strategies for Rural and Safety-net Hospitals
  • Tiny Threats: The Small Aneurysm Controversies (Fireside Chat)
  • Oral Abstract Sessions
  • Digital Oral Poster Sessions (Poster Hall)
9:15 a.m. to 10:45 a.m.
  • Hard to Crack: Comprehensive Strategies for Diagnosing and Treating Acute Large Vessel Occlusion due to Intracranial Atherosclerotic Disease (Bench to Bedside)
  • It Ain’t Only Stroke: Vascular Contributions to Brain Disorders Other Than Stroke
  • Unraveling the Molecular Underpinnings of Brain Injury After Ischemia and Hemorrhage
  • Oral Abstract Sessions
  • Digital Oral Poster Sessions (Poster Hall)
11:00 a.m. to 12:30 p.m.

Opening Main Event

  • Ralph Sacco Outstanding Stroke Research Mentor Award Presentation & Lecture
  • Late-Breaking Clinical Trials
12:30 p.m. to 2:00 p.m.
  • Lunch
  • Digital Oral Poster Sessions and Posters Sessions
2:30 p.m. to 3:30 p.m.
  • "And the Children Shall Lead Them…" Advances in Pediatric Stroke Research for Adult Stroke Neurologists
  • Novel Technologies in Neuro-Intervention (a Stroke: Vascular and Interventional Neurology Journal Session)
  • Perfusion Imaging in Acute Stroke: Past Glory or Promise for the Future? (Debate)
  • Red Blood Cells and Stroke Pathogenesis
  • Oral Abstract Sessions
  • Digital Oral Poster Sessions (Poster Hall)
3:45 p.m. to 4:45 p.m.
  • Intracranial Atherosclerotic Disease (Bench to Bedside)
  • Optimizing Cell Therapy for Stroke
  • Technology-Enhanced Psychosocial Support for Stroke Recovery
  • Oral Abstract Sessions
  • Digital Oral Poster Sessions (Poster Hall)
5:00 p.m. to 6:00 p.m.
  • Intracranial Atherosclerotic Disease (Bench to Bedside)
  • Cancer and Stroke - An Underappreciated Etiology
  • The Use of AR/VR/MR in the Spectrum of Stroke Care
  • Oral Abstract Sessions
  • Digital Oral Poster Sessions (Poster Hall)
Thursday, Feb. 5, 2026 Activities
Time Activity
7:30 a.m. to 9:00 a.m.
  • "Train, Advocate, Measure, Repeat" – Expanding Global Access to Thrombectomy
  • Moyamoya Revisited: Advances in Pathophysiology and Treatment
  • Oral Abstract Sessions
  • Digital Oral Poster Sessions (Poster Hall)
9:15 a.m. to 10:45 a.m.
  • Carotid artery disease in 2026 as informed by randomized trials and other studies
  • Neurocognitive Sequela of Aneurysmal Subarachnoid Hemorrhage
  • Spasticity Management in Post-Stroke Recovery: Discussing Different Case Presentations
  • Stroke in 2026: Navigating Controversies in Ischemic Stroke Treatment (Debate)
  • Oral Abstract Sessions
  • Digital Oral Poster Sessions (Poster Hall)
11:00 a.m. to 12:30 p.m.

Thursday Main Event

  • Willis Award Presentation and Lecture
  • Late-Breaking Clinical Trial Results
12:30 p.m. to 2:00 p.m.
  • Lunch
  • Digital Oral Poster Sessions and Posters Sessions
2:30 p.m. to 3:30 p.m.
  • A Child Shows Up in an Adult Emergency Room: To Reperfuse or Not to Reperfuse? That Is the Question (Debate)
  • GLP-1 Targeted Therapies for Cerebrovascular and Brain Health
  • High Profile Clinical Trials 2026: Reperfusion Therapy
  • Oral Abstract Sessions (including Late-Breaking Science Oral Abstracts)
  • Digital Oral Poster Sessions (Poster Hall)
3:45 p.m. to 4:45 p.m.
  • Beyond City Limits: State of the Art Stroke Care in Prehospital and Rural Settings
  • Embolic Stroke of Undetermined Source: Contemporary Treatment Paradigms (a JAHA Journal Session)
  • Silent Strokes, Loud Consequences: The true impact of covert brain infarcts
  • To HIIT or Not to HIIT: That is Today’s Question for Stroke Care (Bench to Bedside)
  • Oral Abstract Sessions (including Late-Breaking Science Oral Abstracts)
  • Digital Oral Poster Sessions (Poster Hall)
5:00 p.m. to 6:00 p.m.
  • To HIIT or Not to HIIT: That is Today’s Question for Stroke Care (Bench to Bedside)
  • Lessons from negative neuromodulation stroke motor recovery trials
  • Migraine and Stroke: The Double-edged Sword
  • Polygenic Risk Scores in Stroke: From Genomics to Precision Care
  • Game of Strokes
  • Oral Abstract Sessions (including Late-Breaking Science Oral Abstracts)
  • Digital Oral Poster Sessions (Poster Hall)
Friday, Feb. 6, 2026 Activities
Time Activity
7:30 a.m. to 9:00 a.m.
  • Aging Immune System: Implications for Cerebrovascular Disease and Brain Health
  • Brain Health in an Aging Population: Behavioral Risk Reduction (an Alzheimer’s Association / ASA Joint Symposium)
  • Code ICH: reorganizing care of ICH patients (a Neurocritical Care Society / ASA Joint Symposium)
  • Oral Abstract Sessions
9:15 a.m. to 10:45 a.m.
  • Applied Neuroangiography: What a Stroke Neurologist Needs to Know
  • Preclinical Stroke Research Networks: A Critical Assessment of Progress and Potential
  • The Paola De Rango Memorial Session: Sex and Gender Differences Related to Cognitive Impairment and Dementia after Stroke
  • Oral Abstract Sessions
11:00 a.m. to 1:00 p.m.

Closing Main Event

  • Feinberg Award Presentation and Lecture
  • Sherman Award Presentation and Lecture
  • Stroke Council Award Presentation and Lecture
  • Late-Breaking Clinical Trial Results

Learning Objectives

International Stroke Conference

At the conclusion of the International Stroke Conference 2026, participants should be able to:

  • Identify recent advances in basic models of stroke and their translation to clinical research.
  • Evaluate recent advances in the diagnosis, treatment, prevention and rehabilitation of cerebrovascular disease.
  • Analyze new and ongoing advances in clinical research through late-breaking science and ongoing clinical trials sessions.
  • Discuss new research, treatments and interventions with scientists and investigators working in all areas of cerebrovascular disease.
  • Interpret the rapidly changing areas within the stroke spectrum such as emerging options for the diagnosis and treatment of acute stroke, mechanisms of stroke recovery, and the impact of vascular cognitive impairment.
  • Appraise the diverse challenges presented by cerebrovascular disease to specific populations, including ethnic and racial minorities, women, children, and developing communities.
Brain Health Pre-Conference Symposium

At the conclusion of the Brain Health Pre-Conference Symposium, participants should be able to:

  • Describe the interconnections between the heart and the brain as it relates to brain health.
  • Discuss post stroke cognitive and mental health issues including depression, post stroke dementia and loneliness, and resilience after life changing events.
  • Identify modifiable factors related to maintaining a healthy brain.
  • Describe the role of creativity through art and music and how it may affect brain health.
Experimental Stroke Science Pre-Conference Symposium

At the conclusion of the Experimental Stroke Science Pre-Conference Symposium, participants should be able to:

  • Analyze the cellular and molecular mechanisms underlying intracerebral and subarachnoid hemorrhage, including roles of immune cells, complement pathways, and neuroinflammatory processes.
  • Evaluate emerging therapeutic targets and strategies—such as modulation of microglia/macrophage activity, ferroptosis pathways, epigenetic regulation, and endothelial function—to mitigate secondary brain injury and improve outcomes.
  • Apply current evidence on neurovascular protection and repair mechanisms, including hypoxic conditioning, biomarker development, and choroid plexus signaling, to guide clinical and translational research initiatives.
  • Develop approaches to prevent and manage complications of hemorrhagic stroke, such as edema, hydrocephalus, axonal degeneration, and thrombolysis/reperfusion-associated hemorrhage, through innovative interventions and system-based practices.
HEADS-UP Pre-Conference Symposium

At the conclusion of the HEADS-UP Pre-Conference Symposium, participants should be able to:

  • Analyze methodological considerations and lessons learned from designing and conducting randomized controlled trials (RCTs) in low- and middle-income countries (LMICs), including challenges and solutions for data integrity and feasibility.
  • Evaluate strategies to enhance sustainability, generalizability, and cultural relevance of stroke trials in global settings, ensuring equitable representation and applicability of findings.
  • Apply principles of valid subgroup analysis and health equity frameworks to interpret trial outcomes and inform clinical decision-making in diverse populations.
  • Develop evidence-based approaches for conducting health disparities research in stroke and neurology, leveraging lessons from NIH- and NINDS-supported networks and interdisciplinary models to overcome systemic barriers.
Stroke in Practice

At the conclusion of the Stroke in Practice Pre-Conference Symposium, participants should be able to:

  • Analyze current evidence-based strategies for managing carotid stenosis, intracerebral hemorrhage (ICH), and common vascular malformations, including patient selection and procedural considerations.
  • Evaluate best practices for mechanical thrombectomy and advanced imaging interpretation, including MeVo retrieval techniques and CT perfusion (CTP) analysis for optimal decision-making.
  • Apply updated guidelines and clinical evidence to determine timing of anticoagulation after stroke, extended-window thrombolysis, and door-in-door-out transfer protocols to improve patient outcomes.
  • Develop individualized care plans incorporating positioning strategies, patent foramen ovale (PFO) management, and multidisciplinary approaches to optimize stroke treatment across diverse clinical scenarios.
State-of-the-Science Stroke Nursing Symposium

At the conclusion of the State-of-the-Science Stroke Nursing Symposium, participants should be able to:

  • Analyze current evidence-based practices and emerging guidelines for the management of acute ischemic and hemorrhagic stroke, including nursing-specific updates and system-wide coordination strategies.
  • Evaluate innovative care delivery models, palliative interventions, and interdisciplinary approaches that improve patient outcomes and expedite stroke care across diverse healthcare settings.
  • Apply strategies to enhance continuity of care for stroke survivors, ensuring effective transitions within the healthcare system and reducing gaps in post-stroke management.
  • Develop actionable plans to optimize team performance, certification compliance, and quality metrics through standardized protocols and collaborative stroke response initiatives.